1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Avista Corp. reported 2024 full-year earnings of $2.29 per diluted share, up from $2.24 in 2023, and fourth-quarter earnings of $0.84 per diluted share, down from $1.08 a year earlier. The company also initiated 2025 consolidated earnings guidance of $2.52 to $2.72 per diluted share, which shareholders will use to judge the year ahead.
Full-year 2024 net income was $180 million, versus $171 million in 2023; full-year EPS was $2.29 versus $2.24.
Fourth-quarter 2024 net income was $67 million, versus $84 million in the fourth quarter of 2023; quarterly EPS was $0.84 versus $1.08.
2025 consolidated guidance is $2.52 to $2.72 per diluted share, with Avista Utilities expected to contribute $2.43 to $2.61.
The company cited a $0.12 negative midpoint impact from the Energy Recovery Mechanism in its 2025 Avista Utilities guidance.
Chord Energy reported fourth-quarter 2024 net income of $210.6 million ($3.43 diluted per share), down from $301.6 million a year earlier, while oil, NGL and natural gas revenue rose to $1.06 billion from $830.2 million. For full-year 2024, net income was $848.6 million ($16.02 diluted per share) versus $1.02 billion in 2023. The company raised its base dividend about 4% to $1.30 per share and said its 2025 outlook is consistent with its November 2024 three-year plan.
Q4 2024 net income $210.6 million ($3.43 diluted per share) versus $301.6 million ($6.93 diluted) in Q4 2023
Full-year 2024 net income $848.6 million ($16.02 diluted per share) versus $1,023.8 million in 2023
Base dividend of $1.30 per share, up about 4%, payable March 26, 2025 to holders of record March 11, 2025
Repurchased $205.0 million of common stock in Q4 2024; 2025 outlook targets about $860 million of Adjusted Free Cash Flow at $70/Bbl WTI
CAVA reported fourth-quarter and fiscal 2024 results, with revenue, net income and adjusted EBITDA all higher than in the prior year. Fourth-quarter net income of $78.6 million includes an $80.1 million benefit from releasing a valuation allowance on deferred tax assets, and excluding it, adjusted net income was $6.5 million. The company also gave fiscal 2025 guidance for adjusted EBITDA of $150.0 million to $157.0 million.
Fourth-quarter CAVA Revenue rose 28.3% to $225.1 million; fiscal 2024 CAVA Revenue rose 33.1% to $954.3 million
Fiscal 2024 net income was $130.3 million versus $13.3 million in fiscal 2023; excluding the VA Release, adjusted net income was $50.2 million
Fiscal 2025 guidance: adjusted EBITDA of $150.0 million to $157.0 million and CAVA Same Restaurant Sales Growth of 6.0% to 8.0%, compared with 13.4% in fiscal 2024
Extra Space Storage reported fourth-quarter 2024 results. Net income per diluted share rose 21.6% to $1.24, and Core FFO per diluted share rose 0.5% to $2.03, while same-store revenue fell 0.4% and same-store net operating income fell 3.5%. The company expects 2025 Core FFO of $8.00 to $8.30 per diluted share and says it expects a challenging but slowly improving operating environment.
Q4 2024 net income attributable to common stockholders was $1.24 per diluted share, up 21.6% from a year earlier.
Q4 2024 Core FFO was $2.03 per diluted share, up 0.5%; full-year 2024 Core FFO was $8.12, up 0.2%.
Same-store revenue fell 0.4% and same-store NOI fell 3.5% in Q4 2024; year-end same-store occupancy was 93.7%, up from 92.5%.
2025 outlook: Core FFO of $8.00 to $8.30 per diluted share, with same-store revenue growth of (0.75)% to 1.25%.
Permian Resources reported fourth quarter 2024 oil and gas sales of $1.3 billion, up from $1.1 billion a year earlier, while Class A diluted earnings per share fell to $0.29 from $0.51. For full year 2024, sales reached $5.0 billion and diluted EPS was $1.45, compared with $1.24 in 2023. The company also issued 2025 guidance calling for production of 360,000 to 380,000 Boe/d and a capital budget of $1.9 billion to $2.1 billion.
Q4 2024 net income attributable to Class A common stock was $216.7 million, versus $255.4 million in Q4 2023
Full year 2024 oil and gas sales were $5.0 billion, versus $3.1 billion in 2023
2025 guidance: 360,000 to 380,000 Boe/d production and $1.9 billion to $2.1 billion cash capex
Quarterly base dividend declared at $0.15 per share, payable March 31, 2025
Merit Medical reported fourth-quarter and full-year 2024 results on February 25, 2025, with revenue up 9.4% in the quarter and 7.9% for the year. The company also issued 2025 guidance calling for revenue of $1.470 billion to $1.490 billion and non-GAAP earnings per share of $3.58 to $3.70, up 8% to 10% and 4% to 7% from 2024. GAAP earnings per share in the quarter slipped to $0.46 from $0.47 a year earlier.
Q4 2024 revenue was $355.2 million, up 9.4%; GAAP net income was $27.9 million, or $0.46 per diluted share, versus $0.47 a year earlier
Q4 2024 non-GAAP EPS was $0.93, up 25.8% from the prior year period
Full-year 2024 revenue was $1.357 billion, up 7.9%; GAAP EPS was $2.03 versus $1.62 in 2023
2025 guidance: revenue of $1.470 billion to $1.490 billion and non-GAAP EPS of $3.58 to $3.70
Interparfums reported record fourth-quarter and full-year 2024 results, with full-year net sales up 10% to $1.45 billion and diluted EPS of $5.12, up from $4.75. The company reaffirmed its 2025 guidance and raised its annual cash dividend 7% to $3.20 per share, which shareholders should weigh alongside a $4 million impairment loss tied to Rochas Fashion.
Full-year 2024 net sales rose 10% to $1.45 billion; fourth-quarter net sales were $362 million, up 10%.
Full-year diluted EPS was $5.12, or $5.18 before the $4 million impairment loss, versus the $5.15 guidance the company had given.
2025 guidance calls for net sales of $1.51 billion and EPS of $5.35, both up 4%, and was reaffirmed.
Annual cash dividend rate increased to $3.20 from $3.00; next quarterly dividend of $0.80 is payable March 28, 2025, to holders of record on March 14, 2025.
ZoomInfo reported fourth-quarter 2024 revenue of $309.1 million, down 2% from a year earlier, and GAAP operating income of $30.9 million, down 56%. For full-year 2025 it guided to revenue of $1.185 billion to $1.205 billion, below 2024 revenue of $1.214 billion, while adjusted EPS guidance of $0.95 to $0.97 was roughly in line with 2024's $0.96. The board also approved an additional $500 million share repurchase authorization.
Q4 2024 GAAP revenue $309.1 million, down 2% year over year; GAAP diluted EPS $0.04 versus a $0.01 loss a year earlier
Full-year 2024 GAAP revenue $1,214.3 million, down 2%; GAAP diluted EPS $0.08 versus $0.27 in 2023
FY 2025 guidance: revenue $1.185 billion to $1.205 billion; adjusted EPS $0.95 to $0.97
Board approved an additional $500 million share repurchase authorization on February 21, 2025
Safety Insurance Group reported fourth quarter and full-year 2024 results. Full-year net income rose to $70.7 million, or $4.78 per diluted share, from $18.9 million, or $1.28, in 2023, and total revenue passed $1 billion for the first time. Fourth-quarter net income fell to $8.1 million, or $0.55 per diluted share, from $12.3 million, or $0.83, a year earlier.
Full-year 2024 total revenue was $1,120.0 million, up from $931.0 million in 2023.
Full-year 2024 combined ratio was 101.1%, compared with 107.7% in 2023; fourth-quarter combined ratio was 101.9%, compared with 106.5%.
Board approved a $0.90 per share quarterly cash dividend, payable March 14, 2025, to shareholders of record on March 3, 2025.
Full-year direct written premiums rose 20.4% to $1,193.1 million.
EXL reported fourth-quarter 2024 revenue of $481.4 million, up 16.3% from a year earlier, and GAAP diluted EPS of $0.31, up from $0.24. For full-year 2024, revenue was $1.84 billion, up 12.7%, and GAAP diluted EPS was $1.21, up from $1.10. The company guided to 2025 revenue of $2.025 billion to $2.060 billion and adjusted diluted EPS of $1.83 to $1.89, implying growth of 10% to 12% and 11% to 14%, respectively.
Q4 2024 revenue $481.4 million, up 16.3%; GAAP diluted EPS $0.31 vs. $0.24; adjusted diluted EPS $0.44 vs. $0.35
Full-year 2024 revenue $1.84 billion, up 12.7%; GAAP diluted EPS $1.21 vs. $1.10; adjusted diluted EPS $1.65 vs. $1.43
2025 guidance: revenue $2.025 billion to $2.060 billion; adjusted diluted EPS $1.83 to $1.89
New reporting segments and an updated operating model take effect in Q1 2025; conference call set for February 26, 2025 at 10:00 A.M. ET
Gulfport Energy reported a fourth-quarter and full-year 2024 net loss, driven by a $342.7 million impairment of oil and natural gas properties in the fourth quarter, after a profit in 2023. The company also gave 2025 guidance calling for flat total production and a 30%-plus increase in liquids output, with base capital spending of $370 million to $395 million.
Full-year 2024 net loss was $261.4 million, compared with net income of $1.47 billion in 2023; total revenues were $958.1 million, down from $1.79 billion.
Fourth-quarter 2024 net loss was $273.2 million, including a $342.7 million impairment; the same quarter of 2023 had net income of $245.7 million.
Full-year 2024 adjusted EBITDA was $731.1 million, which the company said was above analyst consensus expectations.
2025 guidance: net daily equivalent production of 1.04 to 1.065 Bcfe per day, described as flat, and net daily liquids production of 18.0 to 20.5 MBbl per day.
OUTFRONT Media reported fourth-quarter 2024 revenue of $493.2 million, down 1.6% from the prior year, while net income attributable to the company rose to $74.0 million, or $0.43 per diluted share, from $0.36 a year earlier. The company also declared a $0.30 per share quarterly dividend payable March 31, 2025, and the filing shows its full-year 2024 net income of $258.2 million compared with a loss of $425.2 million in 2023.
Q4 2024 revenue of $493.2 million, down $8.0 million or 1.6% reported; organic revenue up 3.9%
Q4 2024 net income attributable to OUTFRONT of $74.0 million, $0.43 per diluted share, versus $0.36 a year earlier
Quarterly dividend of $0.30 per share, payable March 31, 2025, to holders of record on March 7, 2025
Full-year 2024 net income of $258.2 million versus a net loss of $425.2 million in 2023
UFP Technologies reported fourth-quarter and full-year 2024 results on February 25, 2025. Full-year net sales rose 26.1% to $504.4 million and GAAP diluted EPS was $7.58, compared with $5.83 in 2023, while fourth-quarter sales grew 41.9% to $144.1 million. Long-term debt, less current portion, was $176.9 million at December 31, 2024, up from $28.0 million a year earlier.
Full-year 2024 net income was $59.0 million, up 31.3% from $44.9 million; GAAP diluted EPS was $7.58 versus $5.83.
Fourth-quarter 2024 net sales were $144.1 million, up 41.9%; GAAP diluted EPS was $2.10 versus $1.51.
Full-year MedTech sales rose 30.2% to $450.8 million; gross margin was 29.1% versus 28.1%.
Long-term debt, less current portion, was $176.9 million at December 31, 2024, versus $28.0 million at December 31, 2023.
Caesars Entertainment reported fourth-quarter and full-year 2024 results. Q4 net revenues fell to $2.80 billion from $2.83 billion, while net income attributable to Caesars was $11 million, compared with a net loss of $72 million a year earlier. For the full year, the company posted a net loss of $278 million, versus net income of $786 million in 2023, a decline the company attributes mainly to a $940 million tax valuation allowance release in the prior year.
Q4 2024 net revenues were $2.80 billion versus $2.83 billion; same-store Adjusted EBITDA was $882 million versus $924 million.
Full-year 2024 net revenues were $11.2 billion versus $11.5 billion, and full-year net loss was $278 million versus net income of $786 million.
In Q4, the company used WSOP and Promenade sale proceeds to reduce debt by $500 million and repurchased $50 million of common stock.
As of December 31, 2024, total debt outstanding was $12.3 billion and cash and cash equivalents were $866 million.
SPX Technologies reported fourth-quarter 2024 revenue of $533.7 million, up from $469.4 million, and GAAP diluted EPS of $1.19, up from $0.67. For full-year 2024, GAAP net income rose to $200.5 million from $89.9 million, and the company introduced 2025 full-year adjusted EPS guidance of $6.00 to $6.25. Shareholders get a clear view of stronger 2024 earnings and a 2025 outlook that calls for growth.
Q4 2024 revenue was $533.7 million versus $469.4 million in Q4 2023, and Q4 GAAP diluted EPS was $1.19 versus $0.67.
Full-year 2024 GAAP net income was $200.5 million versus $89.9 million in 2023; full-year adjusted EPS was $5.58 versus $4.31.
2025 guidance targets consolidated revenue of approximately $2.13 to $2.19 billion and adjusted EPS of $6.00 to $6.25.
Keysight reported first quarter fiscal 2025 results for the period ended January 31, 2025, with revenue of $1.30 billion, up from $1.26 billion a year earlier. Non-GAAP earnings per share rose to $1.82 from $1.63, while GAAP net income of $169 million, or $0.97 per share, was slightly below the prior year's $172 million, or $0.98 per share. The company also guided second quarter revenue to $1.27 billion to $1.29 billion and non-GAAP EPS to $1.61 to $1.67.
Revenue was $1.30 billion, compared with $1.26 billion in the first quarter of 2024.
GAAP net income was $169 million, or $0.97 per share, versus $172 million, or $0.98 per share, a year earlier.
Non-GAAP net income was $317 million, or $1.82 per share, versus $286 million, or $1.63 per share.
Second quarter fiscal 2025 guidance: revenue of $1.27 billion to $1.29 billion and non-GAAP EPS of $1.61 to $1.67.
Arcus Biosciences reported fourth-quarter and full-year 2024 results. Full-year revenue rose to $258 million from $117 million and the net loss narrowed to $283 million from $307 million, or $3.14 per share versus $4.15. The company ended the year with $992 million in cash, cash equivalents and marketable securities after completing a $150 million financing, though fourth-quarter net loss widened to $94 million from $81 million.
Full-year 2024 revenue was $258 million, compared with $117 million in 2023
Full-year net loss per share was $3.14, compared with $4.15 in 2023; full-year R&D expenses were $448 million, compared with $340 million
Fourth-quarter 2024 net loss was $94 million, compared with $81 million, on revenue of $36 million versus $31 million
Cash, cash equivalents and marketable securities were $992 million as of December 31, 2024, excluding proceeds from the $150 million financing
Instacart, which files under Maplebear Inc., reported fourth-quarter 2024 results on February 25, 2025, with revenue up 10% year-over-year and GAAP net income up $13 million. The company also gave a first-quarter 2025 outlook calling for adjusted EBITDA of $220 million to $230 million, which it says is up year-over-year, and 2025 stock-based compensation of less than $425 million.
Q4 2024 total revenue was $883 million, up 10% year-over-year, and GTV was $8,645 million, up 10%.
Q4 2024 GAAP net income was $148 million, up $13 million year-over-year; adjusted EBITDA was $252 million, up 27%.
Q4 2024 operating cash flow was $153 million, a decrease of $80 million year-over-year, due to working capital fluctuations.
Q1 2025 outlook: GTV of $9,000 million to $9,150 million and adjusted EBITDA of $220 million to $230 million.
First Solar reported fourth-quarter 2024 net sales of $1.5 billion, up $0.6 billion from the prior quarter, and diluted earnings of $3.65 per share, up from $3.25 a year earlier. The company also gave 2025 guidance of $5.3 billion to $5.8 billion in net sales and $17.00 to $20.00 in earnings per diluted share, which gives shareholders a outlook for the year ahead.
Q4 2024 net sales $1.5 billion; full-year 2024 net sales $4.2 billion, up from $3.3 billion in 2023
Q4 2024 diluted EPS $3.65 vs. $3.25 in Q4 2023; full-year 2024 diluted EPS $12.02 vs. $7.74
2025 guidance: net sales $5.3 billion to $5.8 billion; diluted EPS $17.00 to $20.00; operating income $1.95 billion to $2.30 billion
Year-end 2024 net cash balance of $1.2 billion, up from $0.7 billion at the end of the prior quarter
Matson reported fourth-quarter 2024 net income of $128.0 million, or $3.80 per diluted share, up from $62.4 million, or $1.78, a year earlier, on revenue of $890.3 million compared with $788.9 million. For full-year 2025, the company expects consolidated operating income to be moderately lower than the $551.3 million achieved in 2024 if Red Sea trade normalizes by mid-year, or to approach the 2024 level if disruption continues through year end.
Q4 2024 diluted EPS was $3.80 versus $1.78 in Q4 2023; net income was $128.0 million versus $62.4 million
Q4 2024 consolidated revenue was $890.3 million versus $788.9 million; China freight rates were a primary driver
Q1 2025 consolidated operating income is expected to be meaningfully higher than the $36.9 million in Q1 2024
Full-year 2024 diluted EPS was $13.93 and net income was $476.4 million; a $18.4 million SSAT impairment charge reduced Q4 2024 diluted EPS by $0.42
Grocery Outlet reported fourth-quarter fiscal 2024 net sales up 10.9% to $1.10 billion, but net income fell to $2.3 million, or $0.02 per diluted share, from $14.1 million, or $0.14, a year earlier. The company also issued fiscal 2025 guidance, announced a restructuring plan with $52 million to $61 million in expected total costs, and named Jason Potter as President and CEO.
Q4 net sales rose 10.9% to $1.10 billion; gross margin fell to 29.5% from 30.2%, and net income was $2.3 million versus $14.1 million a year earlier.
Fiscal 2025 outlook: net sales of $4.7 billion to $4.8 billion, adjusted EBITDA of $260 million to $270 million, and adjusted diluted EPS of $0.70 to $0.75.
Restructuring plan expected to cost $52 million to $61 million, of which $36 million to $45 million is cash; it includes terminating leases for 15 stores planned for fiscal 2025 and eight for fiscal 2026.
Jason Potter, who has over 30 years of industry experience and most recently led The Fresh Market, is the new President and CEO.
Workday reported fiscal fourth-quarter 2025 total revenues of $2.211 billion, up 15.0% year over year, and full-year revenues of $8.446 billion, up 16.4%. GAAP diluted EPS fell to $0.35 from $4.42 a year earlier, which the company attributes to $75 million of restructuring expenses and to a $1.1 billion deferred tax benefit recorded in the prior-year period, while non-GAAP diluted EPS rose to $1.92 from $1.57. The company guided fiscal 2026 subscription revenue to $8.800 billion (14% growth) and a non-GAAP operating margin of approximately 28.0%.
Q4 fiscal 2025 total revenues $2.211 billion, up 15.0%; subscription revenues $2.040 billion, up 15.9%
Q4 GAAP diluted EPS $0.35 vs. $4.42 a year earlier; non-GAAP diluted EPS $1.92 vs. $1.57
Full-year fiscal 2025 operating cash flows $2.461 billion; free cash flows $2.192 billion; repurchased shares for $700 million
Fiscal 2026 restructuring plan expected to reduce current workforce by approximately 8%
Intuit reported fiscal second-quarter results for the period ended January 31, 2025, with total revenue of $4.0 billion, up 17 percent, and GAAP diluted earnings per share of $1.67, up 34 percent. The company reiterated its full fiscal 2025 guidance and declared a quarterly dividend of $1.04 per share, a 16 percent increase from the prior-year period.
Global Business Solutions Group revenue rose 19 percent to $2.7 billion; Credit Karma revenue rose 36 percent to $511 million.
Non-GAAP diluted EPS was $3.32, up 26 percent; GAAP operating income was $593 million, up 61 percent.
Full-year fiscal 2025 revenue guidance of $18.160 billion to $18.347 billion was reiterated; third-quarter revenue guidance is $7.550 billion to $7.600 billion.
The $1.04 dividend is payable April 18, 2025, to shareholders of record as of April 10, 2025.
Innovex International reported fourth-quarter 2024 revenue of $251 million, up from $152 million in the third quarter and $133 million a year earlier, and net income of $32 million, compared with $18 million a year earlier. The company also gave first-quarter 2025 revenue guidance of $245 million to $255 million and Adjusted EBITDA guidance of $45 million to $50 million, and its board approved a new $100 million share repurchase program.
Q4 2024 revenue of $251 million, up 65% from Q3 2024 and up from $133 million in Q4 2023; full-year 2024 revenue was $661 million
Q4 2024 net income of $32 million, down from $83 million in Q3 2024 but up from $18 million in Q4 2023; full-year net income was $140 million
Q1 2025 guidance: total revenue of $245 million to $255 million and Adjusted EBITDA of $45 million to $50 million
Board approved a new share repurchase program of up to $100 million on February 25, 2025, replacing prior Dril-Quip plans
MGE Energy reported full-year 2024 net income of $120.6 million, or $3.33 per share, up from $117.7 million, or $3.25 per share, in 2023. Fourth-quarter net income rose to $22.0 million, or 61 cents per share, from $20.1 million, or 55 cents per share, a year earlier. Full-year operating revenues fell to $676.9 million from $690.4 million, which the company attributed in part to warmer-than-normal weather reducing gas deliveries.
Full-year 2024 net income $120.6 million ($3.33 per share) vs. $117.7 million ($3.25) in 2023
Q4 2024 net income $22.0 million (61 cents per share) vs. $20.1 million (55 cents) in Q4 2023
Full-year 2024 operating revenues $676.9 million vs. $690.4 million; Q4 revenues $171.4 million vs. $164.7 million
Gas retail therm deliveries decreased approximately 4% in 2024, mainly due to warmer-than-normal weather
Sempra reported full-year 2024 GAAP earnings of $2.82 billion, or $4.42 per diluted share, down from $3.03 billion, or $4.79, in 2023, while adjusted earnings rose to $2.97 billion, or $4.65 per share, from $2.92 billion, or $4.61. The company revised its 2025 EPS guidance to $4.30 to $4.70, issued 2026 guidance of $4.80 to $5.30, and raised its five-year capital plan to $56 billion, which matters to shareholders because it sets the outlook for earnings and investment.
Full-year 2024 GAAP EPS was $4.42 versus $4.79 in 2023; adjusted EPS was $4.65 versus $4.61, and a $330 million foreign tax credit valuation allowance charge weighed on GAAP results
Fourth-quarter 2024 GAAP EPS was $1.04 versus $1.16; adjusted EPS was $1.50 versus $1.13
2025 EPS guidance revised to $4.30 to $4.70; 2026 EPS guidance of $4.80 to $5.30; long-term EPS growth rate raised to 7% to 9%
Quarterly common dividend declared at $0.645 per share, payable April 15, 2025, an annualized $2.58 per share versus $2.48 in 2024
Public Service Enterprise Group reported full-year 2024 net income of $1.77 billion ($3.54 per share), down from $2.56 billion ($5.13 per share) in 2023, while non-GAAP operating earnings rose to $3.68 per share from $3.48. Operating revenues fell to $10.29 billion from $11.24 billion, and the company initiated 2025 non-GAAP operating earnings guidance of $3.94 to $4.06 per share, with a raised five-year capital spending plan that matters to shareholders for future earnings growth and dividends.
FY 2024 net income $1.77 billion ($3.54 per share) vs. $2.56 billion ($5.13) in FY 2023; non-GAAP operating EPS $3.68 vs. $3.48
FY 2024 operating revenues $10.29 billion vs. $11.24 billion in FY 2023
2025 non-GAAP operating earnings guidance of $3.94 to $4.06 per share; midpoint up about 9% over 2024
2025-2029 capital spending plan raised to $22.5 billion to $26 billion, up $3.5 billion from prior plan; indicative 2025 dividend $2.52 per share, up $0.12
Itron reported fourth-quarter and full-year 2024 results, with revenue up 6% in the quarter to $613 million and up 12% for the year to $2.4 billion. GAAP diluted EPS rose to $1.26 for the quarter and $5.18 for the year, and the company set a record total backlog of $4.7 billion. Its 2025 non-GAAP diluted EPS outlook of $5.20 to $5.60 sits near the $5.62 reported for 2024.
Q4 2024 revenue $613 million, up 6%; full-year revenue $2.4 billion, up 12%
Q4 GAAP diluted EPS $1.26, up $0.30; full-year GAAP diluted EPS $5.18, up $3.07
Full-year 2024 non-GAAP diluted EPS $5.62; 2025 outlook $5.20 to $5.60 on revenue of $2.4 billion to $2.5 billion
Total backlog a record $4.7 billion at December 31, 2024
LGI Homes reported fourth-quarter 2024 results in which home sales revenue, net income and diluted EPS all declined from a year earlier. For full year 2024, revenue fell 6.6% to $2.2 billion and net income fell 1.6% to $196.1 million, while gross margin rose to 24.2%. The company also issued 2025 guidance for 6,200 to 7,000 home closings and cited expected affordability challenges, which matters to shareholders because it sets a near-term outlook for sales and profitability.
Q4 2024: home sales revenues decreased 8.4% to $557.4 million; net income decreased 2.3% to $50.9 million, or $2.15 diluted EPS
Full year 2024: home closings of 6,131 including a bulk sale of 103 leased homes; net income of $196.1 million, or $8.30 diluted EPS
Gross margin rose 120 basis points to 24.2% for 2024; 2025 guidance projects gross margin of 23.2% to 24.2%
2025 guidance: 6,200 to 7,000 home closings and average sales price of $360,000 to $370,000
Pinnacle West reported full-year 2024 net income attributable to common shareholders of $608.8 million, or $5.24 per diluted share, up from $501.6 million, or $4.41, in 2023. The company posted a fourth-quarter net loss of $6.8 million, or $0.06 per diluted share, and said it continues to estimate 2025 earnings of $4.40 to $4.60 per diluted share on a weather-normalized basis.
Full-year 2024 net income attributable to common shareholders was $608.8 million, or $5.24 per diluted share, versus $501.6 million, or $4.41, in 2023.
Fourth-quarter 2024 net loss attributable to common shareholders was $6.8 million, or $0.06 per diluted share, compared with a net loss of $23,000 in the fourth quarter of 2023.
Full-year 2024 operating revenues were $5.12 billion, up from $4.70 billion in 2023; fourth-quarter revenues were $1.10 billion, up from $991.6 million.
2025 EPS guidance of $4.40 to $4.60 per diluted share was reiterated in the company's February 25, 2025 release.
NexPoint Residential Trust reported fourth-quarter 2024 net loss attributable to common stockholders of $26.9 million, or $1.06 per diluted share, compared with net income of $18.4 million, or $0.70 per share, a year earlier. The company also issued initial 2025 guidance calling for a full-year loss of $1.05 to $1.33 per diluted share and Core FFO of $2.56 to $2.83 per diluted share, which shareholders should weigh against 2024 results of $0.04 per share in earnings and $2.79 per share in Core FFO.
Q4 2024 total revenues were $63.8 million, down from $68.9 million in Q4 2023; Q4 FFO was a loss of $6.5 million, or $0.25 per diluted share.
Full-year 2024 net income attributable to common stockholders was $1.1 million, or $0.04 per diluted share, versus $44.3 million, or $1.69 per diluted share, in 2023.
2025 guidance: earnings per diluted share of $(1.33) to $(1.05); Core FFO per diluted share of $2.56 to $2.83, with a midpoint of $2.70 versus $2.79 in 2024.
Same Store NOI guidance for 2025 ranges from -3.5% to 0.5%, with a midpoint of -1.5%.
Harmony Biosciences reported fourth-quarter and full-year 2024 results, with WAKIX net product revenue of $201.3 million for the quarter, up 20% from a year earlier, and $714.7 million for the year, up 23%. The company reiterated its 2025 WAKIX net revenue guidance of $820 million to $860 million and said it reached a settlement in its first generic patent litigation. Quarterly GAAP diluted earnings per share were $0.85, up from $0.45, while full-year 2024 GAAP diluted EPS was $2.51, up from $2.13.
Q4 2024 net product revenue was $201.3 million, compared with $168.4 million in Q4 2023.
Q4 2024 GAAP net income was $49.5 million, or $0.85 per diluted share, versus $26.6 million, or $0.45, a year earlier.
Full-year 2024 net product revenue was $714.7 million; 2025 WAKIX net revenue guidance is $820 million to $860 million, reiterated, not changed.
Full-year 2024 GAAP net income was $145.5 million, or $2.51 per diluted share, including a $25.5 million upfront licensing fee and a $17.1 million IPR&D charge within R&D expenses.
AdaptHealth reported fourth-quarter and full-year 2024 results on February 25, 2025, and gave 2025 guidance. Fourth-quarter net revenue and adjusted EBITDA each fell slightly from the prior-year quarter, while full-year net revenue and adjusted EBITDA rose, and net income swung to a profit of $90.4 million from a loss of $678.9 million. The company's 2025 guidance calls for net revenue of $3.22 billion to $3.36 billion and adjusted EBITDA of $670 million to $710 million.
Q4 2024 net revenue was $856.6 million, down 0.2% from $858.2 million; Q4 adjusted EBITDA was $200.6 million, down 2.0%.
Full-year 2024 net revenue was $3.26 billion, up 1.9%, and adjusted EBITDA was $688.7 million, up 2.7%.
Full-year 2024 net income attributable to AdaptHealth was $90.4 million, compared with a loss of $678.9 million in 2023, which included an $830.8 million goodwill impairment.
2025 guidance: net revenue of $3.22 billion to $3.36 billion, adjusted EBITDA of $670 million to $710 million, and free cash flow of $180 million to $220 million.
DigitalOcean reported fourth-quarter revenue of $205 million, up 13% year-over-year, and full-year 2024 revenue of $781 million, also up 13%, with full-year net income of $84 million. The company initiated first-quarter and full-year 2025 guidance, with 2025 total revenue expected at $870 million to $890 million, and non-GAAP diluted net income per share of $1.85 to $1.95. Separately, director Amy Butte said she will not stand for reelection at the 2025 Annual Meeting, citing no disagreement with the company.
Q4 2024 revenue was $205 million, up 13%; net income attributable to common stockholders was $18 million, up 15%; diluted EPS was $0.19 versus $0.17 a year earlier.
Full-year 2024 revenue was $781 million, up 13%; net income was $84 million; diluted EPS was $0.89 versus $0.20 in 2023.
First-quarter 2025 guidance: total revenue of $207 million to $209 million. Full-year 2025 guidance: total revenue of $870 million to $890 million.
Director Amy Butte, who joined the board in April 2018, notified the company on February 21, 2025 that she will not stand for reelection and will serve through the 2025 Annual Meeting.
Elanco reported fourth-quarter 2024 revenue of $1,020 million, down 1% on a reported basis, and a reported net loss of $8 million, narrower than the $141 million loss a year earlier. For 2025, it guided to adjusted EBITDA of $830 million to $870 million and adjusted EPS of $0.80 to $0.86, both below 2024 levels of $910 million and $0.91, citing about $45 million of foreign exchange headwind to adjusted EBITDA.
Q4 2024 revenue $1,020 million, down 1% reported and up 4% organic constant currency; Q4 adjusted EPS $0.14 vs. $0.08 a year earlier
Full-year 2024 reported net income $338 million vs. a $1,231 million loss in 2023; full-year revenue $4,439 million, flat reported
2025 guidance: revenue $4,445 million to $4,510 million, reported net (loss) income $(25) million to $7 million, adjusted EBITDA $830 million to $870 million
2025 guidance reflects about $110 million revenue and $45 million adjusted EBITDA foreign exchange headwinds; innovation revenue target raised to $640 million to $720 million
Interface reported fourth-quarter 2024 net sales of $335 million, up 3.0% from a year earlier, while adjusted earnings per diluted share fell 17.1% to $0.34. For the full year, net sales rose 4.3% to $1.316 billion and GAAP diluted EPS was $1.48, up from $0.76, and the company repaid $115 million of debt. The company also guided to 2025 full-year net sales of $1.315 billion to $1.365 billion.
Q4 2024 net sales $335 million, up 3.0%; GAAP diluted EPS $0.37 vs. $0.33; adjusted diluted EPS $0.34 vs. $0.41
Q4 2024 adjusted operating income $32.8 million, down 20.0% year over year
Full-year 2024 net sales $1.316 billion, up 4.3%; GAAP diluted EPS $1.48 vs. $0.76
2025 outlook: Q1 net sales $290 million to $300 million; full-year net sales $1.315 billion to $1.365 billion, with FX expected to reduce growth by about 1% to 2%
Xenia Hotels & Resorts reported a fourth-quarter 2024 net loss attributable to common stockholders of $0.6 million, or $0.01 per share, compared with net income of $7.6 million a year earlier, while Same-Property RevPAR rose 5.1%. Adjusted EBITDAre fell 0.5% to $59.2 million and Adjusted FFO per diluted share fell 4.9% to $0.39. The company also gave 2025 guidance and raised its quarterly dividend about 17% to $0.14 per share.
Q4 2024 net loss attributable to common stockholders was $0.6 million, or $0.01 per share, versus net income of $7.6 million in Q4 2023.
Q4 2024 Same-Property RevPAR rose 5.1% to $165.92; Adjusted FFO per diluted share fell 4.9% to $0.39.
2025 guidance: net income of $9 million to $29 million; Same-Property RevPAR change of 3.5% to 6.5%; Adjusted EBITDAre of $244 million to $264 million.
Quarterly dividend increased about 17% to $0.14 per share, payable April 15, 2025 to holders of record on March 31, 2025.
Planet Fitness reported fourth-quarter 2024 revenue of $340.5 million, up 19.4% from a year earlier, and net income attributable to the company of $47.1 million, or $0.56 per diluted share, versus $0.41 a year earlier. For full-year 2024, revenue rose 10.3% to $1.2 billion and diluted EPS was $2.00, compared with $1.62, and the company gave 2025 growth expectations including revenue up approximately 10% and adjusted net income per diluted share up 11% to 12%.
Q4 2024 total revenue rose $55.4 million, or 19.4%, to $340.5 million; equipment segment revenue rose 49.2% to $105.1 million
Full-year 2024 net income attributable to Planet Fitness was $172.0 million, or $2.00 per diluted share, versus $138.3 million, or $1.62, in 2023
2025 outlook calls for same club sales growth of 5% to 6%, revenue up approximately 10%, and adjusted net income per diluted share up 11% to 12%
The company opened 150 clubs in 2024 and ended the year with 19.7 million members
Integra LifeSciences reported fourth-quarter 2024 revenue of $442.6 million, up 11.5% on a reported basis but up 3.5% on an organic basis, and adjusted earnings of $0.97 per diluted share versus $0.89. For full-year 2024 it posted a GAAP net loss of $6.9 million, or $(0.09) per diluted share, and adjusted earnings per share fell to $2.56 from $3.10, with 2025 adjusted EPS guided to $2.41 to $2.51.
Q4 2024 revenue $442.6 million, up 11.5% reported and 3.5% organic; GAAP EPS $0.25 in both Q4 2024 and Q4 2023
Full-year 2024 GAAP net loss $6.9 million, or $(0.09) per diluted share, versus GAAP net income of $67.7 million, or $0.84, in 2023
Full-year 2024 adjusted EBITDA $322.2 million, down $47.4 million; 2025 revenue guidance $1,650 million to $1,715 million
Q1 2025 adjusted EPS guidance $0.40 to $0.45; full-year 2025 adjusted EPS guidance $2.41 to $2.51
LivaNova reported fourth-quarter revenue of $321.8 million, up 3.8%, and full-year 2024 revenue of $1.25 billion, up 8.7%. Full-year 2024 adjusted diluted EPS was $3.38, up from $2.80, and the company guided to 2025 adjusted diluted EPS of $3.65 to $3.75, which is above the 2024 figure.
Q4 2024 revenue $321.8 million, up 3.8% reported; GAAP diluted EPS $1.02 versus $0.30; adjusted diluted EPS $0.81 versus $0.87
Full-year 2024 revenue $1.25 billion, up 8.7%; GAAP diluted EPS $1.16; adjusted diluted EPS $3.38 versus $2.80
2025 guidance: revenue growth of 5.0% to 6.0% on a constant-currency basis; adjusted free cash flow of $135 million to $155 million
Armstrong World Industries reported fourth-quarter 2024 net sales of $367.7 million, up 17.7%, and diluted net earnings per share of $1.42, up 34.0%. For full-year 2024, net sales rose 11.6% to $1,445.7 million and adjusted diluted EPS rose 18.6% to $6.31, and the company issued 2025 guidance calling for adjusted diluted EPS of $6.85 to $7.15.
Q4 2024 net sales $367.7 million, up 17.7%; diluted EPS $1.42 versus $1.06 a year earlier
Full-year 2024 adjusted diluted EPS $6.31 versus $5.32, up 18.6%
2025 guidance: net sales $1,570 million to $1,610 million; adjusted diluted EPS $6.85 to $7.15
$662 million remained under the share repurchase authorization as of December 31, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.